BPC 157 for Foot Pain Houston Podiatrist Explains FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides and synthetic peptides are being sold as wellness products, but make no mistake: they are performance enhancing drugs and prohibited by WADA and USAPL. #TrueToTheMission #LiftClean #USAPL #USAPowerlifting